Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and hydroxyproline

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with hydroxyproline in 4 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Studies
(hydroxyproline)		Trials
(hydroxyproline)		Recent Studies (post-2010) (hydroxyproline)
9,15618755210,9423341,426

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's2 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ono, S; Voelkel, NF1
Dahms, TE; Demello, DE; Ohar, JA; Pantano, J; Waller, KS1
Cevikel, MH; Kozaci, LD; Ozgün, H; Sakarya, S1
At Muhammed, R; El-Medany, A; El-Medany, G; El-Rakhawy, FI; Hagar, HH; Moursi, M1

Other Studies

4 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and hydroxyproline

ArticleYear
PAF receptor blockade inhibits lung vascular changes in the rat monocrotaline model.
    Lung, 1992, Volume: 170, Issue:1

    Topics: Animals; Azepines; Blood Pressure; Hydroxyproline; Hypertension, Pulmonary; Lung; Male; Monocrotaline; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pulmonary Artery; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Thymidine; Triazoles

1992
Chronic platelet-activating factor induces a decrease in pulmonary vascular compliance, hydroxyproline, and loss of vascular matrix.
    American journal of respiratory and critical care medicine, 1994, Volume: 149, Issue:6

    Topics: Animals; Blood Flow Velocity; Blood Pressure; Cell Count; Cell Nucleus; Chronic Disease; Contracture; Drainage; Elastic Tissue; Female; Heart Atria; Hydroxyproline; Infusions, Intravenous; Linear Models; Lung Compliance; Platelet Activating Factor; Pulmonary Artery; Pulmonary Circulation; Rabbits; Tunica Intima; Vascular Resistance

1994
Lexipafant inhibits postsurgical adhesion formation.
    The Journal of surgical research, 2002, Volume: 103, Issue:2

    Topics: Animals; Female; Hydroxyproline; Imidazoles; Interleukin-6; Leucine; Peritoneal Diseases; Platelet Activating Factor; Postoperative Complications; Rats; Rats, Wistar; Tissue Adhesions; Uterus; Wound Healing

2002
Attenuation of bleomycin-induced lung fibrosis in rats by mesna.
    European journal of pharmacology, 2005, Feb-10, Volume: 509, Issue:1

    Topics: Animals; Bleomycin; Drug Administration Schedule; Drug Screening Assays, Antitumor; Glutathione; Hydroxyproline; Injections, Intraperitoneal; Lung; Male; Mesna; Nitric Oxide Synthase; Peptidyl-Dipeptidase A; Peroxidase; Platelet Activating Factor; Pulmonary Fibrosis; Rats; Rats, Wistar; Time Factors; Tumor Necrosis Factor-alpha; Weight Gain; Weight Loss

2005